Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionVan Eck Associates Corp
Latest Disclosed Ownership10,257,215 shares
Latest Disclosed Value $ 622,100
Van Eck Associates Corp reports 2.81% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 10,257,215 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $537,683,210 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 10,553,721 shares of Bristol-Myers Squibb Company. This represents a change in shares of -2.81% during the quarter. The current value of the position is $486,550,994 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Bristol-Myers Squibb COM 110122108 10,257,215 -296,506 -2.81 622 9.31 0.4076
2026-02-13 2025-12-31 13F Bristol-Myers Squibb COM 110122108 10,553,721 693,806 7.04 569 28.15 0.4705
2025-11-13 2025-09-30 13F Bristol-Myers Squibb COM 110122108 9,859,915 5,933,805 151.14 445 145.30 0.4131
2025-08-14 2025-06-30 13F Bristol-Myers Squibb COM 110122108 3,926,110 -1,067,008 -21.37 182 -40.46 0.2057
2025-05-15 2025-03-31 13F Bristol-Myers Squibb COM 110122108 4,993,118 -4,076,708 -44.95 305 -40.62 0.3936
2025-01-29 2024-12-31 13F Bristol-Myers Squibb COM 110122108 9,069,826 -863,765 -8.70 513 -2.85 0.6568
2024-10-29 2024-09-30 13F Bristol-Myers Squibb COM 110122108 9,933,591 781,385 8.54 527 38.68 0.6582
2024-07-31 2024-06-30 13F Bristol-Myers Squibb COM 110122108 9,152,206 1,203,033 15.13 380 -11.83 0.5401
2024-04-30 2024-03-31 13F Bristol-Myers Squibb COM 110122108 7,949,173 3,918,234 97.20 431 109.22 0.6516
2024-02-05 2023-12-31 13F Bristol-Myers Squibb COM 110122108 4,030,939 3,579,324 792.56 207 692.31 0.3763
2023-11-08 2023-09-30 13F Bristol-Myers Squibb COM 110122108 451,615 83,599 22.72 26 13.04 0.0575
2023-08-03 2023-06-30 13F Bristol-Myers Squibb COM 110122108 368,016 27,244 7.99 24 0.00 0.0515
2023-05-03 2023-03-31 13F Bristol-Myers Squibb COM 110122108 340,772 -145,080 -29.86 24 -32.35 0.0538
2023-02-08 2022-12-31 13F Bristol-Myers Squibb COM 110122108 485,852 -26,657 -5.20 35 -99.91 0.0903
2022-10-27 2022-09-30 13F Bristol-Myers Squibb COM 110122108 512,509 18,270 3.70 36,434 -4.26 0.1084
2022-08-03 2022-06-30 13F Bristol-Myers Squibb COM 110122108 494,239 -1,343,021 -73.10 38,056 -71.64 0.1009
2022-05-10 2022-03-31 13F Bristol-Myers Squibb COM 110122108 1,837,260 -1,530,832 -45.45 134,175 -36.11 0.2769
2022-01-26 2021-12-31 13F Bristol-Myers Squibb COM 110122108 3,368,092 267,069 8.61 210,001 14.45 0.4859
2021-11-03 2021-09-30 13F Bristol-Myers Squibb COM 110122108 3,101,023 317,524 11.41 183,487 -1.35 0.4613
2021-08-10 2021-06-30 13F Bristol-Myers Squibb COM 110122108 2,783,499 415,920 17.57 185,993 24.44 0.4400
2021-05-13 2021-03-31 13F Bristol-Myers Squibb COM 110122108 2,367,579 392,331 19.86 149,466 21.99 0.4066
2021-02-09 2020-12-31 13F Bristol-Myers Squibb COM 110122108 1,975,248 148,632 8.14 122,525 11.26 0.3568
2020-12-04 2020-09-30 13F/A-1 Bristol-Myers Squibb COM 110122108 1,826,616 776,505 73.95 110,126 78.35 0.3504
2020-11-12 2020-09-30 13F Bristol-Myers Squibb COM 110122108 1,826,616 776,505 110,126 341,429.5769
2020-08-14 2020-06-30 13F/A-1 Bristol-Myers Squibb COM 110122108 1,050,111 36,906 3.64 61,746 9.33 0.2151
2020-08-10 2020-06-30 13F Bristol-Myers Squibb COM 110122108 1,050,111 36,906 61,746 209,766.6832
2020-05-12 2020-03-31 13F Bristol-Myers Squibb COM 110122108 1,013,205 -830,010 -45.03 56,476 -52.27 0.2868
2020-02-13 2019-12-31 13F Bristol-Myers Squibb COM 110122108 1,843,215 275,262 17.56 118,316 48.80 0.4571
2019-11-08 2019-09-30 13F Bristol-Myers Squibb COM 110122108 1,567,953 685,314 77.64 79,511 98.64 0.3726
2019-08-07 2019-06-30 13F Bristol-Myers Squibb COM 110122108 882,639 154,830 21.27 40,028 15.27 0.1928
2019-05-13 2019-03-31 13F Bristol-Myers Squibb COM 110122108 727,809 35,945 5.20 34,724 -3.45 0.1706
2019-02-12 2018-12-31 13F Bristol-Myers Squibb COM 110122108 691,864 45,599 7.06 35,963 -10.36 0.1804
2018-11-13 2018-09-30 13F Bristol-Myers Squibb COM 110122108 646,265 -17,535 -2.64 40,120 9.21 0.1957
2018-08-13 2018-06-30 13F Bristol-Myers Squibb COM 110122108 663,800 201,430 43.56 36,735 25.61 0.1718
2018-05-11 2018-03-31 13F Bristol-Myers Squibb COM 110122108 462,370 -291,488 -38.67 29,245 -36.69 0.1454
2018-02-12 2017-12-31 13F Bristol-Myers Squibb COM 110122108 753,858 -37,417 -4.73 46,196 -8.41 0.2278
2017-11-09 2017-09-30 13F Bristol-Myers Squibb COM 110122108 791,275 5,451 0.69 50,436 15.19 0.2576
2017-08-11 2017-06-30 13F Bristol-Myers Squibb COM 110122108 785,824 29,369 3.88 43,786 6.44 0.2394
2017-05-11 2017-03-31 13F Bristol-Myers Squibb COM 110122108 756,455 116,064 18.12 41,136 9.92 0.1813
2017-02-09 2016-12-31 13F Bristol-Myers Squibb COM 110122108 640,391 257,822 67.39 37,424 81.42 0.1865
2016-11-14 2016-09-30 13F Bristol-Myers Squibb COM 110122108 382,569 202,675 112.66 20,628 55.91 0.0960
2016-08-12 2016-06-30 13F Bristol-Myers Squibb COM 110122108 179,894 -17,808 -9.01 13,231 4.77 0.0678
2016-05-13 2016-03-31 13F Bristol-Myers Squibb COM 110122108 197,702 -66,519 -25.18 12,629 -30.52 0.0851
2016-02-12 2015-12-31 13F Bristol-Myers Squibb COM 110122108 264,221 5,890 2.28 18,176 18.85 0.1442
2015-11-12 2015-09-30 13F Bristol-Myers Squibb COM 110122108 258,331 -7,725 -2.90 15,293 -13.61 0.1175
2015-08-12 2015-06-30 13F Bristol-Myers Squibb COM 110122108 266,056 42,033 18.76 17,703 22.52 0.1047
2015-05-14 2015-03-31 13F Bristol-Myers Squibb COM 110122108 224,023 -24,412 -9.83 14,449 -1.47 0.0834
2015-02-13 2014-12-31 13F Bristol-Myers Squibb COM 110122108 248,435 -105,116 -29.73 14,665 -18.96 0.0912
2014-11-14 2014-09-30 13F Bristol-Myers Squibb COM 110122108 353,551 30,820 9.55 18,095 15.58 0.0959
2014-08-14 2014-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 322,731 65,717 25.57 15,656 17.26 0.0722
2014-05-08 2014-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 257,014 7,092 2.84 13,352 0.52 0.0663
2014-02-12 2013-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 249,922 -27,356 -9.87 13,283 3.51 0.0671
2013-11-14 2013-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 277,278 18,833 7.29 12,832 11.10 0.0653
2013-08-14 2013-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 258,445 258,445 11,550 0.0629
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.